Derek Hennecke was the founder of a contract development manufacturing company specializing in developing clinical Phase I-III drug products. Derek started the company in 2006 and sold it to a large multinational in 2016.
Derek began as a molecular biologist developing APIs in the late 1980’s. Fluent in four languages, he developed international joint ventures and pharma services businesses around the world, including Canada, Germany, The Netherlands, Mexico and Egypt.